Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb study of Mycobacterium tuberculosis Antigen for Skin Test (EM) in children/adolescents and older adults
CTR20242684Phase 2Active
- Sponsor
- Ambience Healthcare
- Start
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Mycobacterium tuberculosis antigen for skin test (EM) in Tuberculosis (TB), latent tuberculosis infection (LTBI), sponsored by Ambience Healthcare. Started Jul 2024; status: active.
02
Drugs
Mycobacterium tuberculosis antigen for skin test (EM)
03
Conditions
Tuberculosis (TB)latent tuberculosis infection (LTBI)
Beyond the preview
Go deeper on CTR20242684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242684.